Brand and Other Names:colistimethate sodium, Coly Mycin M
- Classes: Antibiotics, Other
Dosing & Uses
Dosage Forms & Strengths
powder for injection
Dosage expressed in terms of colistin base
CrCl >80 mL/min: No dosage adjustment required
CrCl 50-79 mL/min: 2.5-3.8 mg/kg/day IV/IM divided q12hr
CrCl 30-49 mL/min: 2.5 mg/kg/day IV/IM qDay or divided q12hr
CrCl 10-29 mL/min: 1.5 mg/kg IV/IM q36hr
Other Indications & Uses
Gram-neg. infection (e.g., Enterobacter aerogenes, E. coli, Klebsiella, Pseudomonas) unresponsive to other antibiotics
Multi-drug resistant gram-neg. infection
Dosage Forms & Strengths
powder for injection
- 150 mg/vial
Dosage expressed in terms of colistin bas
<12 years old: Safety and efficacy not established
Serious - Use Alternative
Significant - Monitor Closely
Paresthesia, tingling sensation
Acute respiratory failure (inhalation route)
Respiratory tract paralysis
Do not exceed 5 mg/kg/day (as colistin base) with normal renal function (see Dosing for renal impairment)
Not indicated for infections by Proteus or Neisseria (most strains are resistant)
Risk of nephrotoxicity, neurotoxicity; discontinue if elevated BUN/creatinine
Risk of respiratory arrest in myasthenia gravis or concomitant anesthetics or neuromuscular blocking drugs
Risk of C. difficile-associated pseudomembranous colitis
Sedative effects may impair driving, operating machinery
Pregnancy & Lactation
Pregnancy Category: C
Lactation: unknown; use caution
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Normal renal function: 2-3hr
CrCl < 20 mL/min: 10-20 hr
IV: 10 min
Time: 2 hr (IM)
Concentration: 5-7.5 mcg/mL (IM); higher IV
Protein Bound: 50%
Metabolism: colistimethate sodium hydrolyzed in vivo
Metabolites: colistin (active)
Mechanism of Action
Structurally similar to polymyxin B; colistimethate hydrolyzed to colistin in vitro or in vivo
Cationic detergent that damages bacterial cytoplasmic membrane, causing cell death
Additive: erythromycin, hydrocortisone Na-succinate, kanamycin, cefazolin
Additive: amikacin, ascorbic acid, chlormaphenicol, diphenhydramine, heparin, penicillin G Na/K, phenobarbital, polymyxin B, ranitidine, vit B/C
Syringe: ampicillin, penicillin G Na
Reconstitute with 2 mL SWI to obtain a 75 mg/mL solution
IV push: half of daily dose injected over 3-5 min q12 hr
IV infusion: half of daily dose injected over 3-5 min; other half mixed with compatible IV solution and administered 1-2 hr later at 5-6 mg/hr
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Select a box to add or remove a plan.
Select a class to view formulary status for similar drugs